1-8 of 8
human t-lymphotropic virus 1
Close
Sort by
Journal Articles

Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1

Clinical Trials & Observations Global Advances
Jill-Léa Ramassamy, Patricia Tortevoye, Balthazar Ntab, Béatrice Seve, Gabriel Carles, Dominique Gaquière, Yoann Madec, Arnaud Fontanet, Antoine Gessain
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2044–2048.
https://doi.org/10.1182/bloodadvances.2020001628
Published: 2020
Journal Articles

Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1–infected cells

Emi Ikebe, Sahoko Matsuoka, Kenta Tezuka, Madoka Kuramitsu, Kazu Okuma, Makoto Nakashima, Seiichiro Kobayashi, Junya Makiyama, Makoto Yamagishi, Seiichi Oyadomari, Kaoru Uchimaru, Isao Hamaguchi
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1845–1858.
https://doi.org/10.1182/bloodadvances.2019001139
Published: 2020
Includes: Supplemental data
Journal Articles

Guerrero CLH, Yamashita Y, Miyara M, et al. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL. Blood Adv. 2020;4(6):1062-1071.

Journal: Blood Advances
Blood Adv (2020) 4 (8): 1647.
https://doi.org/10.1182/bloodadvances.2020001997
Published: 2020
Journal Articles

Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL

Carmina Louise Hugo Guerrero, Yoshiko Yamashita, Megumi Miyara, Naoki Imaizumi, Megumi Kato, Shugo Sakihama, Masaki Hayashi, Takashi Miyagi, Kaori Karimata, Junnosuke Uchihara, Kazuiku Ohshiro, Junpei Todoroki, Sawako Nakachi, Satoko Morishima, Kennosuke Karube, Yuetsu Tanaka, Hiroaki Masuzaki, Takuya Fukushima
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1062–1071.
https://doi.org/10.1182/bloodadvances.2019001429
Published: 2020
Includes: Supplemental data
Journal Articles

Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence

Abigail M. Druck Shudofsky, Chou-Zen Giam
Journal: Blood Advances
Blood Adv (2019) 3 (4): 564–569.
https://doi.org/10.1182/bloodadvances.2018029322
Published: 2019
Journal Articles

Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States

Clinical Trials & Observations
Luis Malpica, Agustin Pimentel, Isildinha M. Reis, Eduardo Gotuzzo, Lazaros Lekakis, Krishna Komanduri, Thomas Harrington, Glen N. Barber, Juan C. Ramos
Journal: Blood Advances
Blood Adv (2018) 2 (6): 607–620.
https://doi.org/10.1182/bloodadvances.2017011106
Published: 2018
Includes: Supplemental data
Journal Articles

Clonality of HTLV-1–infected T cells as a risk indicator for development and progression of adult T-cell leukemia

Sanaz Firouzi, Amir Farmanbar, Kenta Nakai, Masako Iwanaga, Kaoru Uchimaru, Atae Utsunomiya, Yutaka Suzuki, Toshiki Watanabe
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1195–1205.
https://doi.org/10.1182/bloodadvances.2017005900
Published: 2017
Includes: Supplemental data
Journal Articles

Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α

Beatrice Macchi, Emanuela Balestrieri, Caterina Frezza, Sandro Grelli, Elena Valletta, Ambroise Marçais, Francesca Marino-Merlo, Jocelyn Turpin, Charles R. Bangham, Olivier Hermine, Antonio Mastino, Ali Bazarbachi
Journal: Blood Advances
Blood Adv (2017) 1 (12): 748–752.
https://doi.org/10.1182/bloodadvances.2016001370
Published: 2017
Includes: Supplemental data